Neuroleptic malignant syndrome following administration of risperidone and lithium
Gespeichert in:
Veröffentlicht in: | Journal of clinical psychopharmacology 2003-06, Vol.23 (3), p.315-317 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 317 |
---|---|
container_issue | 3 |
container_start_page | 315 |
container_title | Journal of clinical psychopharmacology |
container_volume | 23 |
creator | Bourgeois, James A Kahn, Debra R |
description | |
doi_str_mv | 10.1097/00004714-200306000-00015 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004714_200306000_00015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12826996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-75fe56fe7af74b5a58b01a16542d4749b82a2f8e873c6e22ab05986e550a6be33</originalsourceid><addsrcrecordid>eNpFkNtKxDAQhnOhuOvhFSQvUJ2kOfVSFk-wKIhel7SdrJE2KUkX2be3uqsODMM_8A3DRwhlcMWg0tcwl9BMFBygBDWnYm4mj8gSuGYFaFEtyGnOH_NWaC5PyIJxw1VVqSV5ecJtij2Ok2_pYHu_CTZMNO9Cl-KA1MW-j58-bKjtBh98npKdfAw0Opp8HjH5LgakNnS099O73w7n5NjZPuPFYZ6Rt7vb19VDsX6-f1zdrIuWG5gKLR1K5VBbp0UjrTQNMMuUFLwT88-N4ZY7g0aXrULObQOyMgqlBKsaLMszYvZ32xRzTujqMfnBpl3NoP5WU_-qqf_U1D9qZvRyj47bZsDuHzx4Kb8ACylinw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuroleptic malignant syndrome following administration of risperidone and lithium</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Bourgeois, James A ; Kahn, Debra R</creator><creatorcontrib>Bourgeois, James A ; Kahn, Debra R</creatorcontrib><identifier>ISSN: 0271-0749</identifier><identifier>DOI: 10.1097/00004714-200306000-00015</identifier><identifier>PMID: 12826996</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Humans ; Lithium Chloride - administration & dosage ; Lithium Chloride - adverse effects ; Male ; Neuroleptic Malignant Syndrome - diagnosis ; Neuroleptic Malignant Syndrome - etiology ; Neuroleptic Malignant Syndrome - psychology ; Risperidone - administration & dosage ; Risperidone - adverse effects</subject><ispartof>Journal of clinical psychopharmacology, 2003-06, Vol.23 (3), p.315-317</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c280t-75fe56fe7af74b5a58b01a16542d4749b82a2f8e873c6e22ab05986e550a6be33</citedby><cites>FETCH-LOGICAL-c280t-75fe56fe7af74b5a58b01a16542d4749b82a2f8e873c6e22ab05986e550a6be33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12826996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bourgeois, James A</creatorcontrib><creatorcontrib>Kahn, Debra R</creatorcontrib><title>Neuroleptic malignant syndrome following administration of risperidone and lithium</title><title>Journal of clinical psychopharmacology</title><addtitle>J Clin Psychopharmacol</addtitle><subject>Adult</subject><subject>Humans</subject><subject>Lithium Chloride - administration & dosage</subject><subject>Lithium Chloride - adverse effects</subject><subject>Male</subject><subject>Neuroleptic Malignant Syndrome - diagnosis</subject><subject>Neuroleptic Malignant Syndrome - etiology</subject><subject>Neuroleptic Malignant Syndrome - psychology</subject><subject>Risperidone - administration & dosage</subject><subject>Risperidone - adverse effects</subject><issn>0271-0749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkNtKxDAQhnOhuOvhFSQvUJ2kOfVSFk-wKIhel7SdrJE2KUkX2be3uqsODMM_8A3DRwhlcMWg0tcwl9BMFBygBDWnYm4mj8gSuGYFaFEtyGnOH_NWaC5PyIJxw1VVqSV5ecJtij2Ok2_pYHu_CTZMNO9Cl-KA1MW-j58-bKjtBh98npKdfAw0Opp8HjH5LgakNnS099O73w7n5NjZPuPFYZ6Rt7vb19VDsX6-f1zdrIuWG5gKLR1K5VBbp0UjrTQNMMuUFLwT88-N4ZY7g0aXrULObQOyMgqlBKsaLMszYvZ32xRzTujqMfnBpl3NoP5WU_-qqf_U1D9qZvRyj47bZsDuHzx4Kb8ACylinw</recordid><startdate>200306</startdate><enddate>200306</enddate><creator>Bourgeois, James A</creator><creator>Kahn, Debra R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200306</creationdate><title>Neuroleptic malignant syndrome following administration of risperidone and lithium</title><author>Bourgeois, James A ; Kahn, Debra R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-75fe56fe7af74b5a58b01a16542d4749b82a2f8e873c6e22ab05986e550a6be33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Humans</topic><topic>Lithium Chloride - administration & dosage</topic><topic>Lithium Chloride - adverse effects</topic><topic>Male</topic><topic>Neuroleptic Malignant Syndrome - diagnosis</topic><topic>Neuroleptic Malignant Syndrome - etiology</topic><topic>Neuroleptic Malignant Syndrome - psychology</topic><topic>Risperidone - administration & dosage</topic><topic>Risperidone - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bourgeois, James A</creatorcontrib><creatorcontrib>Kahn, Debra R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bourgeois, James A</au><au>Kahn, Debra R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroleptic malignant syndrome following administration of risperidone and lithium</atitle><jtitle>Journal of clinical psychopharmacology</jtitle><addtitle>J Clin Psychopharmacol</addtitle><date>2003-06</date><risdate>2003</risdate><volume>23</volume><issue>3</issue><spage>315</spage><epage>317</epage><pages>315-317</pages><issn>0271-0749</issn><cop>United States</cop><pmid>12826996</pmid><doi>10.1097/00004714-200306000-00015</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0271-0749 |
ispartof | Journal of clinical psychopharmacology, 2003-06, Vol.23 (3), p.315-317 |
issn | 0271-0749 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00004714_200306000_00015 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adult Humans Lithium Chloride - administration & dosage Lithium Chloride - adverse effects Male Neuroleptic Malignant Syndrome - diagnosis Neuroleptic Malignant Syndrome - etiology Neuroleptic Malignant Syndrome - psychology Risperidone - administration & dosage Risperidone - adverse effects |
title | Neuroleptic malignant syndrome following administration of risperidone and lithium |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A02%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroleptic%20malignant%20syndrome%20following%20administration%20of%20risperidone%20and%20lithium&rft.jtitle=Journal%20of%20clinical%20psychopharmacology&rft.au=Bourgeois,%20James%20A&rft.date=2003-06&rft.volume=23&rft.issue=3&rft.spage=315&rft.epage=317&rft.pages=315-317&rft.issn=0271-0749&rft_id=info:doi/10.1097/00004714-200306000-00015&rft_dat=%3Cpubmed_cross%3E12826996%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12826996&rfr_iscdi=true |